secwatch.observer — SEC 8-K summary
======================================

Issuer:     HAEMONETICS CORP (HAE)
CIK:        0000313143
Form:       8-K
Filed at:   2026-07-28T20:28:06+00:00
Accession:  0000313143-26-000095
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Haemonetics elects Martin Madaus to board; shareholders approve additional LTIP shares
--------------------------------------------------------------------------------

- Martin Madaus elected to board effective July 24, 2026; will serve on Audit and Governance Committees.
- Shareholders approved amendment to 2019 LTIP, authorizing 4,680,000 additional shares and extending term to 2036.
- Shareholders approved amendment to ESPP, extending term to 2036.
- Advisory vote on executive compensation passed with 93.5% of votes cast in favor (39.2M for, 0.57M against).
- All eight director nominees elected; Christopher A. Simon received 39.7M votes for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/313143/000031314326000095/0000313143-26-000095-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/313143/000031314326000095/hae-20260724.htm
  HTML page:      https://secwatch.observer/filing/0000313143-26-000095

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer